Folate and pyridoxine to ssri in major depression and residual cognitive Decline
Sign Up to like & getrecommendations! Published in 2017 at "European Psychiatry"
DOI: 10.1016/j.eurpsy.2017.01.752
Abstract: Introduction Depressive disorders are very common conditions, lifetime risk for experiencing major depression is approximately 15%. Objective Patients with major depression having an insufficient response to SSRI may benefit from addition of methylfolate and pyridoxine.… read more here.
Keywords: pyridoxine; depression; major depression; folate pyridoxine ... See more keywords